{"id":34567,"date":"2019-10-30T12:00:00","date_gmt":"2019-10-30T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/"},"modified":"2019-10-30T12:00:00","modified_gmt":"2019-10-30T12:00:00","slug":"evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/","title":{"rendered":"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l&#8217;aide de la technologie mobile"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--2761 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h3>Le projet mySinusitisCoach d&#8217;EUFOREA<\/h3>\n<p>La rhinosinusite chronique (RSC) est une maladie inflammatoire chronique associ\u00e9e \u00e0 un fardeau personnel et socio-\u00e9conomique consid\u00e9rable. Le suivi des r\u00e9sultats rapport\u00e9s par les patients via la technologie mobile offre la possibilit\u00e9 de mieux comprendre le fardeau de la RSC en vie r\u00e9elle. Cette \u00e9tude rend compte de l&#8217;\u00e9valuation transversale des donn\u00e9es de 626 utilisateurs de mySinusitisCoach (mSC), une application mobile destin\u00e9e aux patients atteints de RSC. Les caract\u00e9ristiques des patients utilisateurs de mSC ont \u00e9t\u00e9 analys\u00e9es, ainsi que le niveau de contr\u00f4le de la maladie bas\u00e9 sur le score VAS global des sympt\u00f4mes de rhinosinusite et les crit\u00e8res EPOS adapt\u00e9s.   <\/p>\n<p>Les donn\u00e9es en vie r\u00e9elle confirment la charge \u00e9lev\u00e9e de la maladie chez les patients atteints de RSC non contr\u00f4l\u00e9e, impactant clairement la qualit\u00e9 de vie. La chirurgie des sinus am\u00e9liore les r\u00e9sultats rapport\u00e9s par les patients, mais pas chez ceux ayant des ant\u00e9c\u00e9dents de plus de 3 proc\u00e9dures. La technologie mobile ouvre une nouvelle \u00e8re de surveillance en vie r\u00e9elle, soutenant l&#8217;\u00e9volution des soins vers une m\u00e9decine de pr\u00e9cision.  <\/p>\n<p><strong>Co-auteurs :<\/strong> Sven F. Seys, Shana De Bont, Wytske J. Fokkens, Claus Bachert, Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie, Paolo Castelnuovo, Russell Cathcart, Jannis Constantinidis, Leen Cools, Marjolein Cornet, Tony Cox, Lieve Delsupehe, Jaime Correia-de-Sousa, Geert De Vos, Zuzana Diamant, Maria Doulaptsi, Philippe Gevaert, Claire Hopkins, Val\u00e9rie Hox, Thomas Hummel, Werner Hosemann, Raf Jacobs, Mark Jorissen, Anette Kjeldsen, Basile N. Landis, Winde Lemmens, Andreas Leunig, Valerie Lund, Gert Mari\u00ebn, Joaquim Mullol, Metin Onerci, Susanna Palkonen,<br \/>\nIsabel Proano, Emmanuel Prokopakis, Dermot Ryan, Herbert Riechelmann, Pernilla Sahlstrand-Johnson, Sanna Salmi-Toppila, Christine Segboer, Kato Speleman, Andreas Steinsvik, Pavol Surda, Peter-Valentin Tomazic, Olivier Vanderveken, Benedicte Verhaeghe, Martin Wagenmann, Laura Van Gerven, Thibaut Van Zele, Jan Verfaillie, Kathie Vierstraete, Stephan Vlaminck, Benoit Pugin, Peter W. Hellings<\/p>\n<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/all.14408\" target=\"_blank\" rel=\"noopener\"><strong>Lire l&#8217;article ici<\/strong><\/a><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph photo-gallery paragraph-id--2768 paragraph--type--photo-gallery paragraph--view-mode--default clearfix p-photo-gallery--col\">\n<div class=\"photo-gallery__content\">\n<div class=\"paragraph photo paragraph-id--2762 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GRAPHICAL20ABSTRACT1.png\" data-caption=\"GRAPHICAL ABSTRACT\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GRAPHICAL-ABSTRACT.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2763 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/F20I20G20U20R20E201202020Evaluation20of20disease20control20and20impact20of20sinusitis20symptoms20on20sleep20quality20and20daily20life20activities3.png?itok=MiPHCoCq%20\" data-caption=\"Figure 1. Evaluation of disease control and impact of sinusitis symptoms on sleep quality and daily life activities.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/F-I-G-U-R-E-1-Evaluation-of-disease-control-and-impact-of-sinusitis-symptoms-on-sleep-quality-and-daily-life-activities.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2764 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/FIGURE20220-20Comparison20of20global20and20specific20rhinosinusitis20symptoms20between20CRSsNP20and20CRSwNP20phenotypes1.png?itok=evtMK-NP%20\" data-caption=\"Figure 2. Comparison of global and specific rhinosinusitis symptoms between CRSsNP and CRSwNP phenotypes.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/FIGURE-2-Comparison-of-global-and-specific-rhinosinusitis-symptoms-between-CRSsNP-and-CRSwNP-phenotypes.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2765 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure20320-20Analysis20of20the20major20symptom20between20CRSsNP20and20CRSwNP20phenotypes1.png\" data-caption=\"Figure 3. Analysis of the major symptom between CRSsNP and CRSwNP phenotypes.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-3-Analysis-of-the-major-symptom-between-CRSsNP-and-CRSwNP-phenotypes.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2766 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure20420-20Prevalence20of20self-reported20asthma20A20and20burden20of20bronchial20symptoms20B20in20mSC20users1.png\" data-caption=\"Figure 4. Prevalence of self-reported asthma (A) and burden of bronchial symptoms (B) in mSC users.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-4-Prevalence-of-self-reported-asthma-A-and-burden-of-bronchial-symptoms-B-in-mSC-users.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2767 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure5-Evaluation-of-global-and-specific-rhinosinusitis-symptoms-in-CRS-patients-stratified-by-the-number-of-functional-endoscopic-sinus-surgery-FESS-procedures.png\" data-caption=\"Figure 5. Evaluation of global and specific rhinosinusitis symptoms in CRS patients stratified by the number of functional endoscopic sinus surgery (FESS) procedures.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-5-Evaluation-of-global-and-specific-rhinosinusitis-symptoms-in-CRS-patients-stratified-by-the-number-of-functional-endoscopic-sinus-surgery-FESS-procedures.png?h=7f64b33b&#038;itok=0pf0glQ3\"><br \/>\n<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le projet mySinusitisCoach d&#8217;EUFOREA La rhinosinusite chronique (RSC) est une maladie inflammatoire chronique associ\u00e9e \u00e0 un fardeau personnel et socio-\u00e9conomique consid\u00e9rable. Le suivi des r\u00e9sultats rapport\u00e9s par les patients via la technologie mobile offre la possibilit\u00e9 de mieux comprendre le fardeau de la RSC en vie r\u00e9elle. Cette \u00e9tude rend compte de l&#8217;\u00e9valuation transversale des donn\u00e9es de 626 utilisateurs de mySinusitisCoach (mSC), une application mobile destin\u00e9e aux patients atteints de RSC. Les caract\u00e9ristiques des patients utilisateurs de mSC ont \u00e9t\u00e9 analys\u00e9es, ainsi que le niveau de contr\u00f4le de la maladie bas\u00e9 sur le score VAS global des sympt\u00f4mes de rhinosinusite et les crit\u00e8res EPOS adapt\u00e9s. Les donn\u00e9es en vie r\u00e9elle confirment la charge \u00e9lev\u00e9e de la maladie chez les patients atteints de RSC non contr\u00f4l\u00e9e, impactant clairement la qualit\u00e9 de vie. La chirurgie des sinus am\u00e9liore les r\u00e9sultats rapport\u00e9s par les patients, mais pas chez ceux ayant des ant\u00e9c\u00e9dents de plus de 3 proc\u00e9dures. La technologie mobile ouvre une nouvelle \u00e8re de surveillance en vie r\u00e9elle, soutenant l&#8217;\u00e9volution des soins vers une m\u00e9decine de pr\u00e9cision. Co-auteurs : Sven F. Seys, Shana De Bont, Wytske J. Fokkens, Claus Bachert, Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie, Paolo Castelnuovo, Russell Cathcart, Jannis Constantinidis, Leen Cools, Marjolein Cornet, Tony Cox, Lieve Delsupehe, Jaime Correia-de-Sousa, Geert De Vos, Zuzana Diamant, Maria Doulaptsi, Philippe Gevaert, Claire Hopkins, Val\u00e9rie Hox, Thomas Hummel, Werner Hosemann, Raf Jacobs, Mark Jorissen, Anette Kjeldsen, Basile N. Landis, Winde Lemmens, Andreas Leunig, Valerie Lund, Gert Mari\u00ebn, Joaquim Mullol, Metin Onerci, Susanna Palkonen, Isabel Proano, Emmanuel Prokopakis, Dermot Ryan, Herbert Riechelmann, Pernilla Sahlstrand-Johnson, Sanna Salmi-Toppila, Christine Segboer, Kato Speleman, Andreas Steinsvik, Pavol Surda, Peter-Valentin Tomazic, Olivier Vanderveken, Benedicte Verhaeghe, Martin Wagenmann, Laura Van Gerven, Thibaut Van Zele, Jan Verfaillie, Kathie Vierstraete, Stephan Vlaminck, Benoit Pugin, Peter W. Hellings Lire l&#8217;article ici<\/p>\n","protected":false},"author":1,"featured_media":34588,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[266],"tags":[195,284,194],"class_list":["post-34567","news","type-news","status-publish","has-post-thumbnail","hentry","category-publications","tag-maladies-respiratoires-chroniques-mrc","tag-publications","tag-rhinosinusite-chronique-rsc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l&#039;aide de la technologie mobile - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l&#039;aide de la technologie mobile\" \/>\n<meta property=\"og:description\" content=\"Le projet mySinusitisCoach d&#8217;EUFOREA La rhinosinusite chronique (RSC) est une maladie inflammatoire chronique associ\u00e9e \u00e0 un fardeau personnel et socio-\u00e9conomique consid\u00e9rable. Le suivi des r\u00e9sultats rapport\u00e9s par les patients via la technologie mobile offre la possibilit\u00e9 de mieux comprendre le fardeau de la RSC en vie r\u00e9elle. Cette \u00e9tude rend compte de l&#8217;\u00e9valuation transversale des donn\u00e9es de 626 utilisateurs de mySinusitisCoach (mSC), une application mobile destin\u00e9e aux patients atteints de RSC. Les caract\u00e9ristiques des patients utilisateurs de mSC ont \u00e9t\u00e9 analys\u00e9es, ainsi que le niveau de contr\u00f4le de la maladie bas\u00e9 sur le score VAS global des sympt\u00f4mes de rhinosinusite et les crit\u00e8res EPOS adapt\u00e9s. Les donn\u00e9es en vie r\u00e9elle confirment la charge \u00e9lev\u00e9e de la maladie chez les patients atteints de RSC non contr\u00f4l\u00e9e, impactant clairement la qualit\u00e9 de vie. La chirurgie des sinus am\u00e9liore les r\u00e9sultats rapport\u00e9s par les patients, mais pas chez ceux ayant des ant\u00e9c\u00e9dents de plus de 3 proc\u00e9dures. La technologie mobile ouvre une nouvelle \u00e8re de surveillance en vie r\u00e9elle, soutenant l&#8217;\u00e9volution des soins vers une m\u00e9decine de pr\u00e9cision. Co-auteurs : Sven F. Seys, Shana De Bont, Wytske J. Fokkens, Claus Bachert, Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie, Paolo Castelnuovo, Russell Cathcart, Jannis Constantinidis, Leen Cools, Marjolein Cornet, Tony Cox, Lieve Delsupehe, Jaime Correia-de-Sousa, Geert De Vos, Zuzana Diamant, Maria Doulaptsi, Philippe Gevaert, Claire Hopkins, Val\u00e9rie Hox, Thomas Hummel, Werner Hosemann, Raf Jacobs, Mark Jorissen, Anette Kjeldsen, Basile N. Landis, Winde Lemmens, Andreas Leunig, Valerie Lund, Gert Mari\u00ebn, Joaquim Mullol, Metin Onerci, Susanna Palkonen, Isabel Proano, Emmanuel Prokopakis, Dermot Ryan, Herbert Riechelmann, Pernilla Sahlstrand-Johnson, Sanna Salmi-Toppila, Christine Segboer, Kato Speleman, Andreas Steinsvik, Pavol Surda, Peter-Valentin Tomazic, Olivier Vanderveken, Benedicte Verhaeghe, Martin Wagenmann, Laura Van Gerven, Thibaut Van Zele, Jan Verfaillie, Kathie Vierstraete, Stephan Vlaminck, Benoit Pugin, Peter W. Hellings Lire l&#8217;article ici\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GRAPHICAL-ABSTRACT.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/\",\"name\":\"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l'aide de la technologie mobile - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png\",\"datePublished\":\"2019-10-30T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l&#8217;aide de la technologie mobile\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l'aide de la technologie mobile - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l'aide de la technologie mobile","og_description":"Le projet mySinusitisCoach d&#8217;EUFOREA La rhinosinusite chronique (RSC) est une maladie inflammatoire chronique associ\u00e9e \u00e0 un fardeau personnel et socio-\u00e9conomique consid\u00e9rable. Le suivi des r\u00e9sultats rapport\u00e9s par les patients via la technologie mobile offre la possibilit\u00e9 de mieux comprendre le fardeau de la RSC en vie r\u00e9elle. Cette \u00e9tude rend compte de l&#8217;\u00e9valuation transversale des donn\u00e9es de 626 utilisateurs de mySinusitisCoach (mSC), une application mobile destin\u00e9e aux patients atteints de RSC. Les caract\u00e9ristiques des patients utilisateurs de mSC ont \u00e9t\u00e9 analys\u00e9es, ainsi que le niveau de contr\u00f4le de la maladie bas\u00e9 sur le score VAS global des sympt\u00f4mes de rhinosinusite et les crit\u00e8res EPOS adapt\u00e9s. Les donn\u00e9es en vie r\u00e9elle confirment la charge \u00e9lev\u00e9e de la maladie chez les patients atteints de RSC non contr\u00f4l\u00e9e, impactant clairement la qualit\u00e9 de vie. La chirurgie des sinus am\u00e9liore les r\u00e9sultats rapport\u00e9s par les patients, mais pas chez ceux ayant des ant\u00e9c\u00e9dents de plus de 3 proc\u00e9dures. La technologie mobile ouvre une nouvelle \u00e8re de surveillance en vie r\u00e9elle, soutenant l&#8217;\u00e9volution des soins vers une m\u00e9decine de pr\u00e9cision. Co-auteurs : Sven F. Seys, Shana De Bont, Wytske J. Fokkens, Claus Bachert, Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie, Paolo Castelnuovo, Russell Cathcart, Jannis Constantinidis, Leen Cools, Marjolein Cornet, Tony Cox, Lieve Delsupehe, Jaime Correia-de-Sousa, Geert De Vos, Zuzana Diamant, Maria Doulaptsi, Philippe Gevaert, Claire Hopkins, Val\u00e9rie Hox, Thomas Hummel, Werner Hosemann, Raf Jacobs, Mark Jorissen, Anette Kjeldsen, Basile N. Landis, Winde Lemmens, Andreas Leunig, Valerie Lund, Gert Mari\u00ebn, Joaquim Mullol, Metin Onerci, Susanna Palkonen, Isabel Proano, Emmanuel Prokopakis, Dermot Ryan, Herbert Riechelmann, Pernilla Sahlstrand-Johnson, Sanna Salmi-Toppila, Christine Segboer, Kato Speleman, Andreas Steinsvik, Pavol Surda, Peter-Valentin Tomazic, Olivier Vanderveken, Benedicte Verhaeghe, Martin Wagenmann, Laura Van Gerven, Thibaut Van Zele, Jan Verfaillie, Kathie Vierstraete, Stephan Vlaminck, Benoit Pugin, Peter W. Hellings Lire l&#8217;article ici","og_url":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/GRAPHICAL-ABSTRACT.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/","url":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/","name":"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l'aide de la technologie mobile - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png","datePublished":"2019-10-30T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Real-life20Assessment20of20Chronic20Rhinosinusitis20Patients20Using20Mobile20Technology20Teaser.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/evaluation-en-vie-reelle-des-patients-atteints-de-rhinosinusite-chronique-a-laide-de-la-technologie-mobile\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"\u00c9valuation en vie r\u00e9elle des patients atteints de rhinosinusite chronique \u00e0 l&#8217;aide de la technologie mobile"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=34567"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34567\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/34588"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=34567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=34567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=34567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}